Clinical Outcomes and Histologic Findings of Patients With Hepatocellular Carcinoma With Durable Partial Response or Durable Stable Disease After Receiving Atezolizumab Plus Bevacizumab
接受阿特珠单抗联合贝伐珠单抗治疗后获得持久部分缓解或持久疾病稳定的肝细胞癌患者的临床结果和组织学发现
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.24.00645
Shen, Ying-Chun; Liu, Tsung-Hao; Nicholas, Alan; Soyama, Akihiko; Yuan, Chang-Tsu; Chen, Tse-Ching; Eguchi, Susumu; Yoshizumi, Tomoharu; Itoh, Shinji; Nakamura, Noriaki; Kosaka, Hisashi; Kaibori, Masaki; Ishii, Takamichi; Hatano, Etsuro; Ogawa, Chikara; Naganuma, Atsushi; Kakizaki, Satoru; Cheng, Chih-Hsien; Lin, Po-Ting; Su, Yung-Yeh; Chuang, Chien-Huai; Lu, Li-Chun; Wu, Chi-Jung; Wang, Hung-Wei; Rau, Kun-Ming; Hsu, Chih-Hung; Lin, Shi-Ming; Huang, Yi-Hsiang; Hernandez, Sairy; Finn, Richard S; Kudo, Masatoshi; Cheng, Ann-Lii